from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2169c/-

LFCtreatmentdescriptionclass of inhibitor

-0.378

Amikacinug/mL Amikacintranslation

-0.857

Cap5-10ug/mL Capreomycintranslation

0.660

Rox10-50 ug/mL Roxithromycintranslation

-0.638

SM2-5 ug/mL Streptomycintranslation

-0.080

Tet5-10 ug/mL Tetracyclinetranslation

0.762

Rif0.2-5ug/mL Rifampicintranscription

-0.208

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.086

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.867

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.601

CPZ10-50 ug/mL Chlorpromazinerespiration

0.119

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.356

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.652

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.305

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.349

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.720

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.549

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.569

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.207

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.084

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.534

KCN5-20 ug/mL Potassium cyaniderespiration

-0.358

NaN30.2-2 mM Sodium aziderespiration

-0.185

Nigericin50 uM Nigericinrespiration

1.281

TRC10-150 ug/mL Triclosanrespiration

1.238

TRZ10-25 ug/mL Thioridazinerespiration

-0.192

Valinomycin0.5-10 uM Valinomycinrespiration

-1.418

ZnSO42 mM ZnSO4respiration

0.030

menadione6-10 ug/mL Menadionerespiration

-0.456

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.774

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.431

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.205

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.367

NRP_1Non-replicating persistence stage 1dosRassociated

-0.391

Amp0.2mg/mL AmpicillincellWall

-0.575

Cephalexin20-100 ug/mL CephalexincellWall

-0.836

Cerulenin0.32-5 ug/mL CerulenincellWall

0.667

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.146

EMB10-20 ug/mL EthambutolcellWall

-0.936

Eta12-40 ug/mL EthionamidecellWall

-0.893

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.092

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.571

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.879

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.305

BZA0.12 mg/mL BenzamidearomaticAmides

0.241

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.215

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.174

H2O24 mM hydrogen peroxideDNAdamaging

-0.747

Levo10 ug/mL LevofloxacinDNAdamaging

-0.490

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.814

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.094

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.447

UVUV-irradiationDNAdamaging

0.003

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.813

Antimycin12.5-50 ug/mL Antimycin A?

-1.148

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.436

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.613

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.875

PA8240.2-2 ug/mL PA-824?

0.776

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.008

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.196

Verapamil50 uM Verapamil?

-1.013

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.601

methoxatin10-20 ug/mL Methoxatin?